Albatroz Therapeutics

Developer of therapeutic antibodies for cancer and arthritis

placeSingapore, Singapore, Singapore calendar_todayFounded 2020 language albatroztherapeutics.com

Registered entities

Innovation

4 patent families — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace active. Cited 497 times.

YearFilings
20241
20252
20262

Social engagement

Social engagement: 1.5K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Outram Bio, Seeds Capital.

Investor typeCountShare
Venture capital110%
Private equity110%
Other / undisclosed880%
Coming soon